CHICAGO, Feb. 22, 2016 /PRNewswire/ -- When Rebecca Bell, founder of medical products provider RBELL Medical, heard about a woman who was severely burned last summer in an office fire set by a disgruntled former coworker, she knew she had to help. So in September, Bell donated RBELL Medical's beta scaffolding mask, made of 100% activated beta-glucan, to aid in the woman's care. Within days, the burns were visibly improved--and Bell realized the beta-glucan product, which had previously been used successfully in aesthetic procedures such as post-operative collagen induction therapy and post-operative scar care, could have a profound impact in wound care as well. RBELL Medical is now bringing 100% activated beta-glucan sheets to physicians under the name RaphaDerma™.
Beta-glucan is a naturally occurring substance, a fibrous polysaccharide (complex sugar) extracted from the cell walls of yeast, bacteria, cereal grain fiber and fungi. Five decades' worth of research indicates beta-glucan has powerful immune system effects, including activating macrophages, the large white blood cells that direct other white blood cells, speed wound healing, and engulf diseased cells to clear cellular debris and kill tumor cells and other pathogens. When applied to wounds in the form of RaphaDerma sheets, beta-glucan can speed wound healing and ease pain associated with procedures like debridement.
"When the victim of the office gasoline fire began treatment with our beta-glucan product, we were hopeful it would aid in her recovery," Bell explained. "I was aware it had applications for burn treatment, but I had no idea it was capable of producing the therapeutic effect we saw in this case. The results in 10 days were amazing, and she has continued to improve since that time. We knew complex wound care providers could use this product in sheeting for their patients, and that has proven to be the case. I have personally seen RaphaDerma sheets ease the pain and trauma of pediatric wound debridement, and that alone is extremely rewarding."
Research backs up Bell's observations. In a study published in the January 2001 issue of the Journal of Pediatric Surgery, researchers at the Medical University of South Carolina's Division of Pediatric Surgery found that combining collagen with beta-glucan to treat partial thickness burns in pediatric burn victims was able to eliminate daily dressing changes--a source of considerable pain and trauma to children who are already dealing with the trauma of the burn event itself--while wounds continued to heal underneath the beta-glucan/collagen application.
In addition to burns and debridement, RaphaDerma 100% activated bega-glucan sheets can be particularly useful in cases of chronic wounds and foot ulcers associated with diabetes: In a clinical study published in the May/June 2012 issue of the Journal of Cutaneous Medicine and Surgery, beta-glucan was shown to significantly speed closure and healing of diabetes-related wounds over previously reported results from other methods.
"We are excited and humbled to see physicians' initial response to RBELL Medical's RaphaDerma sheets," said Bell. "Our goal with RaphaDerma is improved wound care and healing for patients, and we look forward to helping providers achieve that goal."
RaphaDerma is available to complex wound care providers through CleoPen, a division of RBELL Medical.
About RBell Medical LLC
RBELL Medical's mission is to improve the care and outcomes of people by becoming the leading source of credible, quality resources. The company delivers superior service to its providers and emphasizes giving back, most notably in its program offering free scar revision to wounded combat veterans.
RBELL Medical is the parent company of RBELL Radiation, The Cleo Pen and RBELL Beauty. All RBELL Medical companies share the same ethos of compassionate care.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/rbell-medical-advances-complex-wound-care-300223642.html
SOURCE RBELL Medical LLC